Skip to main content
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2018 Nov 29;9:2890. doi: 10.3389/fmicb.2018.02890

Echinococcus granulosus Infection Results in an Increase in Eisenbergiella and Parabacteroides Genera in the Gut of Mice

Jianling Bao 1,2, Huajun Zheng 3,4, Yuezhu Wang 3, Xueting Zheng 1, Li He 1, Wenjing Qi 1, Tian Wang 1, Baoping Guo 1, Gang Guo 1, Zhaoxia Zhang 1, Wenbao Zhang 1,2,*, Jun Li 1,*, Donald P McManus 5
PMCID: PMC6281689  PMID: 30555437

Abstract

Cystic echinococcosis (CE) is a chronic infectious disease caused by Echinococcus granulosus. To confirm whether the infection impacts on the gut microbiota, we established a mouse model of E. granulosus infection in this study whereby BALB/c mice were infected with micro-cysts of E. granulosus. After 4 months of infection, fecal samples were collected for high-throughput sequencing of the hypervariable regions of the 16S rRNA gene. Sequence analysis revealed a total of 13,353 operational taxonomic units (OTUs) with only 40.6% of the OTUs having genera reference information and 101 of the OTUs were significantly increased in infected mice. Bioinformatics analysis showed that the common core microbiota were not significantly changed at family level. However, two genera (Eisenbergiella and Parabacteroides) were enriched in the infected mice (PAMOV A < 0.05) at genus level. Functional analysis indicated that seven pathways were altered in the E. granulosus Infection Group compared with the Uninfected Group. Spearman correlation analysis showed strong correlations of IgG, IgG1 and IgG2a with nine major genera. E. granulosus cyst infection may change the gut microbiota which may be associated with metabolic pathways.

Keywords: Echinococcus granulosus, cystic echinococcosis, mice, microbiome, immunoglobins

Introduction

Cystic echinococcosis (CE) is a cosmopolitan zoonosis caused by the cystic stage of the dog tapeworm Echinococcus granulosus (McManus et al., 2012). The disease causes serious health problems and economic losses, especially in Central Asia (including western China), northern Africa and South America (McManus et al., 2012). E. granulosus requires two hosts [an intermediate host including sheep, goats, cattle or wild herbivores and a definitive host such as dogs (or wolves and other carnivores)] to complete its life-cycle. Humans also become infected as an incidental host by ingesting eggs released from E. granulosus in carnivore feces. After hatching in the stomach and intestine, the eggs (oncospheres) penetrate the gut mucosa, enter the blood circulation and finally develop in internal organs mainly the liver (70%) and lungs (20%) of humans. Serological studies showed that in endemic areas, 4–26% of the population were seropositive against E. granulosus antigens (Gavidia et al., 2008), indicating that a large number of individuals had been infected. CE infection strongly impacts on host immune responses (Zhang et al., 2003, 2012) with high levels of antibodies, particularly IgG1, IgG4 and IgE (Zhang et al., 2003) and predominant Th2 cytokines including IL-4, IL-5, IL-6, and IL-10 (Rigano et al., 1997; Casaravilla et al., 2014), indicating that the host immune response against CE differs from a bacterial or viral infection (Zeng et al., 2017).

The gut microbiota play an important role in human health (Chen et al., 2017) impacting on metabolism, immunity, development and the behavior of the host (Thaiss et al., 2016). In addition, microbiota components are impacted by medical conditions such as cancer (Jensen et al., 2015; O’Keefe, 2016; Sonnenburg and Backhed, 2016). Similar changes occur in experimental models as well (Gkouskou et al., 2014; Yu et al., 2018). Studies showed that helminth infection in the gut induced typical Th2 immune responses which may control the mcriobiota in the gut of mice (Ramanan et al., 2016; Guernier et al., 2017; Wegener Parfrey et al., 2017). However, it is not known whether E. granulosus infection impacts on the gut microbiota of humans or mice. Mice have been used for E. granulosus larval infection including primary (Zhang et al., 2001) and secondary infection (Gottstein, 2001; Mourglia-Ettlin et al., 2016). Mice models play an important role in studies of developmental biology and host specificity in echinococcosis (Nakaya et al., 2006). Recently, mouse models were successfully used for drug screening and development (Elissondo et al., 2007; Wang et al., 2017). To increase the success of secondary infection, we developed a method using micro-cysts cultured in vitro to infect mice (Zhang et al., 2005), and obtained more than 70% of cyst recovery from 50 PSC-generated cysts.

In this study, BALB/C mice were infected with micro-cysts of E. granulosus and their fecal samples were collected for sequencing the variable regions of 16S rRNA genes of gut commensal bacteria to determine their composition and diversity. We show that E. granulosus impacted on the gut microbiota of the mice with microbiota changes likely being associated with the altered host immune status in infected individuals.

Materials and Methods

Ethics Statement

The protocols for using mice in the study were approved by the Ethics Committee of The First Affiliated Hospital of Xinjiang Medical University (FAH-XMU, Approval No. IACUC-20120625003). The “Guidelines for the Care of Laboratory Animals” by the Ministry of Science and Technology of the People’s Republic of China (2006) were rigidly followed in the use of these animals.

Preparation of Cultured E. granulosus Hydatid Cysts

Fresh E. granulosus sensu stricto protoscoleces (PSC) were aspirated from hydatid cysts from sheep livers collected from a slaughterhouse in Urumqi, Xinjiang Uyghur Autonomous Region, China. The PSC were digested with 1% (w/v) pepsin and cultured to obtain echinococcal cysts using published procedures (Zhang et al., 2005; Wang et al., 2014).

Animal Infection and Sample Collection

Pathogen-free female BALB/c mice, aged 6 weeks, were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. All animals were housed at the animal facility of the FAH-XMU. The BALB/c mice were randomly divided into two groups: E. granulosus infected group (Infected Group) and uninfected group (Uninfected Group). The mice in the E. granulosus Infection Group were intraperitoneally (i.p) transplanted with 35 small (diameter, 200–300 μm) hydatid cysts suspended in 0.4 mL RPMI 1640 medium through a 1.0 mL syringe as described in our previous study (Zhang et al., 2005; Wang et al., 2016). Every mouse in the Uninfected Group was i.p. injected with 1.0 mL RPMI 1640 medium. After 4 months, the stool of each mouse was collected daily and about 1 g stool was collected over 1 week. The stool samples were stored at -80°C until use.

Antibody Isotype and Subtype Assays

Mice were sacrificed after the last fecal sample collection, then serum samples were obtained from peripheral blood and stored at -20°C for use. The sera were analyzed by ELISA for different immunoglobulins to hydatid cyst fluid (HCF) including IgG, IgG1, IgG2a, IgG2b and IgG3 and IgM. In brief, each well of MaxiSorb immune-plates (Nunc International) was coated with 100 μL of sheep HCF antigens at a concentration of 2 mg/mL in carbonate/bicarbonate buffer (pH 9.6) (Kittelberger et al., 2002) and incubated overnight at 4°C. After three washes with PBS, the wells were each blocked with 200 μL of 5% (v/v) skim milk in PBS for 1 h at 37°C. Mouse serum was diluted 1–200. For each well, 100 μL of the diluted serum was added and incubated at 37°C for 1 h. After three washes with PBS containing 0.05% Tween 20 (PBST), each well was added 100 μL of diluted anti-mouse monoclonal IgG, IgG1, IgG2a, IgG2b and IgG3 and IgM conjugate (BETHYL). The reaction was developed by adding 100 μL of 2,2-azino-di-[ethyl-benzothiazoline sulfonate] substrate solution (Sigma). After incubation for 30 min in the dark at room temperature, optical density values were read at 405 nm by an ELISA reader (Thermo, Waltham, United States).

Echinococcal Cyst Number and Size

The abdominal cavity of each mouse was opened after sacrifice, and hydatid cysts in the cavity were removed and the numbers of hydatid cysts were counted and their sizes were measured.

PCR Amplification and 16S rRNA Gene Sequencing

Genomic DNA was extracted from stool samples using KAPA HiFi HotStart ReadyMix Kits (Kapa Biosciences, Woburn, MA, United States). The V3–V4 hypervariable region of the 16S rRNA gene was amplified by PCR and sequenced; the length of the V3–V4 hypervariable region was approximately 469 bp. Amplicon pools were prepared for sequencing with AMPure XT beads (Beckman Coulter Genomics, Danvers, MA, United States) and quantification with the Library Quantification Kit for Illumina (Kapa Biosciences, Woburn, MA, United States), respectively. The libraries were sequenced on 300PE MiSeq runs.

Bioinformatics and Statistical Analysis

Mothur (version 1.39.5) was used to assemble the paired FASTQ files (Schloss et al., 2011). The selected quality DNA sequences were confirmed using the following criteria: (1) no contaminant sequences, (2) containing no ambiguous bases, (3) the size length ≥350 bp, (4) containing no chimeric sequences, and (5) primers were trimmed. The average length of selected DNA sequences was 414 bp (350–446 bp). The selected DNA sequences were then grouped into operational taxonomic units (OTUs) by comparing with SILVA reference databases (V128) (Quast et al., 2013) at 97% similarity. The minimum reads number of samples (24,097) was used for data normalization. Community richness, evenness and diversity analysis (Shannon, Simpson, Shannoneven, Simpsonenven, ACE, Chao and Good’s coverage) were analyzed using the Mothur T-test (with 95% confidence intervals, p-value <0.05). Taxonomy was assigned using the online software Ribosomal Database Project (RDP) classifier (80% threshold) (Wang et al., 2007) based on the RDP (Cole et al., 2009). LEfSe (Segata et al., 2011) was also performed to detect abundance taxa (p-value <0.05) between the two groups and estimate linear discriminant analysis effect size (LDA score >2.0). Then Mothur was performed to check the LEfSe results using “metastats” command. Differences among the two groups were also assessed using Analysis of Molecular Variance (AMOVA) in Mothur. Microbiome functions were analyzed using PICRUSt (Langille et al., 2013) based on the KEGG pathways by normalizing the 16S rRNA copy numbers. The input file (biom file) of PICRUSt was calculated using the Mothur software command “classify.otu” and “make.biom”, and then the input file was uploaded to the online PICRUSt for function analysis. Differences were determined using STAMP (Parks et al., 2014).

Correlation of Antibody Isotypes and Bacteria

Statistical analysis program-R Package was performed to calculate the coefficient relationship between bacterial genera present and immunoglobulin isotypes using the non-parametric Spearman rank correlation algorithm. A coefficient of >0.68 or <-0.68 was considered to represent strong correlation (Taylor, 1990).

Results

Infection and Blood Serum Isotypes

In this study 14 mice were transplanted with 35 micro-cysts of E. granulosus. All the mice were successfully infected with an average number of 16 (SD ± 7.0) cysts and an average size of 6.4 mm (0.1–21 mm) in diameter (Table 1). Serological antibody tests showed that these infected mice had a predominantly IgG1 antibody response against HCF antigens, followed by IgG2b, IgG2a and IgG3 (Figure 1), indicating E. granulosus infection induced a predominant Th2 response.

Table 1.

The number and average size of cysts in the E. granulosus infection group.

Eg1 Eg2 Eg3 Eg4 Eg5 Eg11 Eg12 Eg13 Eg14 Eg15 Eg31 Eg32 Eg33 Eg35
Number of cysts 12 15 17 37 21 16 17 14 15 11 12 8 23 13
Average size of cysts(cm) 0.58 0.54 0.58 0.72 0.74 0.55 0.67 0.42 0.49 0.71 0.55 0.75 1.01 0.77

Eg, mice infected with E. granulosus.

FIGURE 1.

FIGURE 1

IgG antibody isotypes and subtypes in sera of mice infected with E. granulosus. p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.005, ∗∗∗∗p < 0.001.

Bacterial Populations in the Stool Samples

Stool samples from the 25 mice were collected for gastrointestinal microbiota analysis, including 14 samples from the mice infected with cysts of E. granulosus (Infected Group) and 11 control samples from mice without infection (Uninfected Group,). A total of 1,383,569 16S rRNA genes were identified by high-throughput DNA sequencing analysis after filtering through quality control filters. The gene numbers ranged from 24,097 (from one in Uninfected Group) to 86,478 genes. To normalize the data to avoid statistical bias, 24,097 genes from the mice with the lowest gene number were used as a baseline for normalization of all the sequences. OTU (97% similarity) analysis was used to estimate richness, evenness and diversity of the bacterial communities. A total of 13,353 OTUs were obtained including 9,118 OTUs from mice infected with E. granulosus, and 8,423 OTUs from the uninfected mice (Table 2). No significant difference was evident between the two groups of mice in term of OTU numbers (p > 0.05). The Good’s coverage was over 93.5% (93.5∼97.8%) for each sample, and over 98% for the two groups, respectively (Table 2), meaning that the sequencing depth was sufficient to undertake microbiota analysis with two groups.

Table 2.

The diversity evaluation of the microbiomes of mice infected with cystic echinococcosis and uninfected mice.

Richness
Evenness
Diversity
Group Sample OTUs Coverage (%) Chao ACE Simpsoneven Shannoneven Shannon Simpson
Infected 14 9,118 98.50 18,212.718 26,873.315 0.01444 0.646977 5.899138 0.007595
Uninfected 11 8,423 98.25 16,846.368 25,099.202 0.01675 0.660714 5.972012 0.007084

Infected, mice infected with E. granulosus; Uninfected, uninfected mice; OTUs, operational taxonomic units; Chao, Chao index, ACE, ACE index.

Core Microbiome in the Gut of Mice

Ribosomal Database Project analysis showed that 99.7% of the 16S rRNA genes were aligned into nine phyla with the common bacteria Firmicutes, Bacteroidetes and Proteobacteria being dominant in both infected and uninfected groups. RDP analysis clustered 93.5% of the genes (OTUs) into 58 families and 13 families were identified as the major taxa and core microbiomes co-existing in the two groups. The genes in those families accounted for 91.61 and 94.27% of the microbiome community in the infected group and uninfected group, respectively (Table 3). Among the 13 families, Lachnospiraceae was mostly predominant in both groups, accounting for 41.42 and 43.92% of the total microbiome, respectively. Ruminococcaceae and Porphyromonadaceae were also dominant (>10% of the entire microbiome in both groups).

Table 3.

The major families of microbiota in E. granulosus infected mice and uninfected mice.

Family Uninfected (%) Infected (%) p-value
Lachnospiraceae 41.42 43.92 p > 0.05
Porphyromonadaceae 14.21 15.75 p > 0.05
Ruminococcaceae 11.52 10.87 p > 0.05
Rikenellaceae   6.61   5.33 p > 0.05
Bacteroidaceae   5.80   5.93 p > 0.05
Helicobacteraceae   3.31   3.94 p > 0.05
Prevotellaceae   2.32   1.94 p > 0.05
Desulfovibrionaceae   1.94   2.30 p > 0.05
Coriobacteriaceae   0.14   0.20 p > 0.05
Deferribacteraceae   1.82   2.73 p > 0.05
Lactobacillaceae   1.80   0.90 p > 0.05
Enterobacteriaceae   0.39   0.17 p > 0.05
Erysipelotrichaceae   0.33   0.29 p > 0.05

Uninfected, uninfected mice; Infected, mice infected with E. granulosus.

Among the 58 families, 40.4% of genes (OUTs) have genus reference information and were aligned into 105 classified genera (Figure 2). There were 57 genera co-existing in both groups. However, there were 24 genera present in the Infection Group and another 24 genera in the Uninfected Group. The proportion of all the group unique genera was less than 0.01%, and no significant differences were found between the two groups.

FIGURE 2.

FIGURE 2

Networks of all bacterial genera revealed in E. granulosus uninfected and infected animal groups. Green circle: the unique genera of the Uninfected Group; red circle: the unique genera of Infected Group. In pie charts, green and red represents the genus proportion of the uninfected and infected animal groups; all the pie charts present all the genera common in both groups. Circle sizes represent the read numbers.

Among the 105 classified genera, 33 were core genera (with each genus comprising >0.1% of total the microbiome), including Bacteroides, Odoribacter, Clostridium XlVa, Helicobacter, Alistipes, Barnesiella and Mucispirillum (Table 4). Among the predominant genera, there were 27 ubiquitous (core) genera which were consistently found in all samples and comprised more than 38% of the total microbiome.

Table 4.

The abundance of genera (>0.1%) in the gut microbiomes of E. granulosus infected mice and uninfected mice determined by LEfSe analysis.

Order Family Genus Feature Uninfected (%) Infected (%) p-value
Coriobacteriales Coriobacteriaceae Enterorhabdus Ubiquitous 0.06 0.08
Bacteroidales Bacteroidaceae Bacteroides Ubiquitous 5.80 5.93
Bacteroidales Porphyromonadaceae Barnesiella Ubiquitous 2.06 2.99
Bacteroidales Porphyromonadaceae Odoribacter Ubiquitous 3.86 4.33
Bacteroidales Porphyromonadaceae Parabacteroides Ubiquitous 0.29 0.56 0.023976
Bacteroidales Prevotellaceae Alloprevotella Ubiquitous 1.55 1.13
Bacteroidales Prevotellaceae Prevotella Ubiquitous 0.73 0.80
Bacteroidales Rikenellaceae Rikenella Ubiquitous 1.81 1.67
Deferribacterales Deferribacteraceae Mucispirillum Ubiquitous 1.81 2.72
Lactobacillales Lactobacillaceae Lactobacillus Ubiquitous 1.80 0.90
Clostridiales Clostridiaceae 1 Clostridium sensu stricto 0.12 0.17
Clostridiales Lachnospiraceae Acetatifactor Ubiquitous 1.10 1.01
Clostridiales Lachnospiraceae Clostridium XlVa Ubiquitous 2.70 4.19
Clostridiales Lachnospiraceae Clostridium XlVb Ubiquitous 0.40 0.28
Clostridiales Lachnospiraceae Dorea Ubiquitous 0.10 0.07
Clostridiales Lachnospiraceae Eisenbergiella 0.02 0.35 0.001998
Clostridiales Lachnospiraceae Lachnospiraceae incertae_sedis Ubiquitous 0.56 0.61
Clostridiales Lachnospiraceae Roseburia Ubiquitous 0.06 0.11
Clostridiales Ruminococcaceae Anaerotruncus Ubiquitous 0.31 0.31
Clostridiales Ruminococcaceae Butyricicoccus Ubiquitous 0.35 0.35
Clostridiales Ruminococcaceae Clostridium IV Ubiquitous 0.04 0.05
Clostridiales Ruminococcaceae Flavonifractor Ubiquitous 1.62 1.78
Clostridiales Ruminococcaceae Intestinimonas Ubiquitous 0.15 0.11 0.035964
Clostridiales Ruminococcaceae Oscillibacter Ubiquitous 1.69 1.29
Clostridiales Ruminococcaceae Pseudoflavonifractor Ubiquitous 0.68 0.73
Clostridiales Ruminococcaceae Ruminococcus 0.13 0.02
Erysipelotrichales Erysipelotrichaceae Erysipelotrichaceae incertae_sedis Ubiquitous 0.21 0.14
Erysipelotrichales Erysipelotrichaceae Turicibacter 0.03 0.10
Desulfovibrionales Desulfovibrionaceae Bilophila 0.03 0.03
Desulfovibrionales Desulfovibrionaceae Desulfovibrio Ubiquitous 0.34 0.67
Campylobacterales Helicobacteraceae Helicobacter Ubiquitous 3.31 3.94
Enterobacteriales Enterobacteriaceae Escherichia/Shigella Ubiquitous 0.39 0.17
Anaeroplasmatales Anaeroplasmataceae Anaeroplasma 0.16 0.10

Uninfected, uninfected mice; Infected, mice infected with E. granulosus. significantly different between uninfected mice and infected mice; ubiquitous, the genus was identified as present in all samples.

At the OTU level, there were significant differences between the two groups; 101 OTUs were significantly increased and 49 OTU were significantly decreased in the infected mouse group (p < 0.05) (Table 5). Of note, most (59.6%) OTUs were unclassified into genera as no classification information is available for these OTUs.

Table 5.

The abundance of OTU (p < 0.01) in the infected mice and uninfected mice determined by LEfSe analysis.

#OTU Taxonomy Uninfected: mean rel.freq.(%) Infected: mean rel.freq.(%) p-values
OTU00452 Clostridiales;Lachnospiraceae;Clostridium XlVa 0.0139587 0.04387 0.000351
OTU00048 Desulfovibrionales;Desulfovibrionaceae;unclassified_Desulfovibrionaceae 0.0067907 0.934319 0.000472
OTU00409 Clostridiales;Lachnospiraceae;Acetatifactor 0.0033954 0.040906 0.001051
OTU00832 Desulfovibrionales;Desulfovibrionaceae;unclassified_Desulfovibrionaceae 0 0.013043 0.001199
OTU01146 Clostridiales;Lachnospiraceae;unclassified_Lachnospiraceae 0.0075453 0.000296 0.001367
OTU01119 Clostridiales;Lachnospiraceae;unclassified_Lachnospiraceae 0.0003773 0.005336 0.001834
OTU00050 Bacteroidales;Porphyromonadaceae;Parabacteroides 0.1011065 0.450856 0.002202
OTU00186 Clostridia;Clostridiales;unclassified_Clostridiales 0.1844817 0.046538 0.00282
OTU00122 Clostridiales;Lachnospiraceae;Eisenbergiella 0.0211267 0.335252 0.002849
OTU00410 Clostridiales;Ruminococcaceae;Oscillibacter 0.0045272 0.034681 0.003348
OTU00058 Campylobacterales;Helicobacteraceae;Helicobacter 0.0580985 0.596103 0.003788
OTU00720 Clostridia;Clostridiales;unclassified_Clostridiales 0.0015091 0.01245 0.00456
OTU01984 Desulfovibrionales;Desulfovibrionaceae;unclassified_Desulfovibrionaceae 0 0.002668 0.006591
OTU01307 Clostridiales;Lachnospiraceae;unclassified_Lachnospiraceae 0.0003773 0.004743 0.007635
OTU01051 Bacteria;Firmicutes;unclassified_Firmicutes 0.0003773 0.007411 0.007741
OTU02591 Desulfovibrionales;Desulfovibrionaceae;unclassified_Desulfovibrionaceae 0 0.001779 0.008089
OTU01588 Bacteroidales;Porphyromonadaceae;Odoribacter 0.0033954 0.000296 0.008438
OTU00715 Desulfovibrionales;Desulfovibrionaceae;unclassified_Desulfovibrionaceae 0.0120724 0.003261 0.008709
OTU00460 Clostridiales;Lachnospiraceae;unclassified_Lachnospiraceae 0.0049044 0.049206 0.009747

Bacterial Composition in Different Groups

LEfSe analysis showed the composition of the bacterial populations in the guts of the infected and uninfected mice was similar, whereas richness, evenness and diversity were only slightly changed (Table 2 and Figure 3). In contrast, AMOVA analysis showed significant difference between the two groups for the microbiota (PAMOV A = 0.029). Species richness (OTU, ACE and Chao index) was higher in the E. granulosus Infected Group, and the evenness (Shannoneven and Simpsoneven) was lower in this group compared with the uninfected mice. As richness and evenness combined, there was no significant difference in the diversity between the two groups (p > 0.5). Consequently, the results of these analyses indicated that E. granulosus infection did not alter much of the composition of the core bacteria present in the mouse gut significantly, although some rare bacteria in very low abundance were increased.

FIGURE 3.

FIGURE 3

The microbial diversity variability in mice infected (Infected Group) or uninfected (Uninfected Group) with E. granulosus. LEfSe analysis showed the composition of the bacterial populations in the guts of the infected and uninfected mice was similar, whereas richness, evenness and diversity were no changed.

Among the 13 core families, LEfSe analysis showed no significant difference between the E. granulosus Infected Group and Uninfected Group in terms of microbiome. Among the major abundant genera, three showed significant differences between the groups (Table 4, LDA > 2, p < 0.05). The infected mice significantly increases two genera, including Eisenbergiella (1.9 times) and Parabacteroides (17.5 times) compared with the uninfected mice (p < 0.05).

Predicted Functional Potential Changes in the Microbiomes of the E. granulosus Infection and Uninfected Groups

We used PICRUSt to predict and compare the microbial functional potential changes between the two groups. A total of 47 Kos were found to be significantly increased in the Infected Group (p < 0.05) (Table 6). At KEGG level 3, 7 pathways were identified as being significant difference (p < 0.05) between the Infected Group and Uninfected Group, and the changed pathways belonged to the metabolism category, including “Biotin metabolism,” “Biosynthesis and Biodegradation of secondary metabolites,” “Ether lipid metabolism,” “Steroid biosynthesis,” “Aminobenzoate degradation,” “Tryptophan metabolism” and “Limonene and pinene degradation.”

Table 6.

Functional predictions using the PICRUSt base on 16S rRNA gene copy numbers.

KO accession Annotation Infected Uninfected p-value
K00655 1-acyl-sn-glycerol-3-phosphate acyltransferase [EC:2.3.1.51] 17,607 15,826 0.01887
K02312 2,3-dihydroxybenzoate-AMP ligase [EC:2.7.7.58] 4,214 3,074 2.43E-02
K01826 5-carboxymethyl-2-hydroxymuconate isomerase [EC:5.3.3.10] 2 0 0.015531
K01905 Acetyl-CoA synthetase (ADP-forming) [EC:6.2.1.13] 4,216 3,063 0.02436
K12554 Alanine adding enzyme [EC:2.3.2.-] 1 0 0.020538
K05341 Amylosucrase [EC:2.4.1.4] 4,223 3,068 0.023681
K03325 Arsenite transporter, ACR3 family 5,022 3,773 1.16E-02
K01338 ATP-dependent Lon protease [EC:3.4.21.53] 15,636 13,406 0.023016
K01305 Beta-aspartyl-dipeptidase (metallo-type) [EC:3.4.19.-] 4,245 3,082 0.023369
K01012 Biotin synthetase [EC:2.8.1.6] 15,209 12,941 0.013677
K03519 Carbon-monoxide dehydrogenase medium subunit [EC:1.2.99.2] 4,219 3,067 0.024608
K01647 Citrate synthase [EC:2.3.3.1] 14,507 12,412 0.023345
K01739 Cystathionine gamma-synthase [EC:2.5.1.48] 4,250 3,105 0.023501
K00901 Diacylglycerol kinase [EC:2.7.1.107] 5,333 4,032 0.012241
K11754 Dihydrofolate synthase/folylpolyglutamate synthase [EC:6.3.2.12 6.3.2.17] 26,899 24,234 0.011904
K07458 DNA mismatch endonuclease, patch repair protein [EC: 3.1.-.-] 4,883 3,692 0.01095
K06212 Formate transporter 4,268 3,116 0.021367
K13892 Glutathione transport system ATP-binding protein 4,226 3,072 0.024579
K04653 Hydrogenase expression/formation protein HypC 7,620 6,473 0.017468
K04654 Hydrogenase expression/formation protein HypD 7,624 6,475 0.016744
K04655 Hydrogenase expression/formation protein HypE 7,696 6,567 0.019062
K04656 Hydrogenase maturation protein HypF 7,630 6,479 0.016758
K04652 Hydrogenase nickel incorporation protein HypB 7,888 6,740 0.021211
K09384 Hypothetical protein 4,225 3,076 2.37E-02
K09703 Hypothetical protein 4,217 3,064 0.024347
K07301 Inner membrane protein 8,454 7,324 0.000592
K03779 L(+)-tartrate dehydratase alpha subunit [EC:4.2.1.32] 4,264 3,106 0.024966
K00879 L-fuculokinase [EC:2.7.1.51] 4,246 3,099 0.023788
K08369 MFS transporter, putative metabolite:H+ symporter 4,280 3,112 0.021188
K02018 Molybdate transport system permease protein 10,849 8,353 2.09E-02
K03637 Molybdenum cofactor biosynthesis protein C 5,564 4,311 0.024072
K07474 Phage terminase small subunit 4,318 3,190 0.022446
K02759 PTS system, cellobiose-specific IIA component [EC:2.7.1.69] 4,336 3,207 0.022898
K02760 PTS system, cellobiose-specific IIB component [EC:2.7.1.69] 4,448 3,372 0.019282
K02777 PTS system, glucose-specific IIA component [EC:2.7.1.69] 4,677 3,516 0.016117
K10026 Queuosine biosynthesis protein QueE 4,760 3,668 2.47E-02
K12996 Rhamnosyltransferase [EC:2.4.1.-] 4,219 3,080 0.024267
K03086 RNA polymerase primary sigma factor 17,918 16,008 3.41E-03
K05297 Rubredoxin-NAD+ reductase [EC:1.18.1.1] 4,352 3,216 0.020307
K03438 S-adenosyl-methyltransferase [EC:2.1.1.-]; 16S rRNA (cytosine1402-N4)-methyltransferase [EC:2.1.1.199] 16,924 15,121 0.014162
K07313 Serine/threonine protein phosphatase 1 [EC:3.1.3.16] 5,067 3,888 0.010963
K02945 Small subunit ribosomal protein S1 16,311 14,363 1.68E-03
K05814 sn-glycerol 3-phosphate transport system permease protein 4,248 3,118 0.023484
K11928 Sodium/proline symporter 4,419 3,257 0.022096
K01695 Tryptophan synthase alpha chain [EC:4.2.1.20] 9,531 8,500 0.021878
K07665 Two-component system, OmpR family, copper resistance phosphate regulon response regulator CusR 7,719 6,661 0.012516
K04784 Yersiniabactin non-ribosomal peptide synthetase 4,212 3,062 0.024426
Average 2,156 2,116

The numbers of Infected and Uninfected were the normalization of copy numbers. Uninfected, uninfected mice; Infected, mice infected with E. granulosus.

Correlations Between Bacterial Composition and Immunoglobulin Isotypes

Spearman correlation analysis showed strong correlations of IgG, IgG1 and IgG2a with nine major genera (Table 7 and Figure 4). The numbers of Enterorhabdus, Barnesiella and Clostridium XlVa were positively correlated with IgG1, IgG2a and IgG2b levels, respectively. IgA was positively associated with increased numbers of genera Clostridium IV, Lachnospiraceae Incertae sedis and Mucispirillum. In addition, IgG, IgG1, IgG2b and IgG3 were associated with decreased numbers of genera Escherichia/Shigella, Ruminococcus, Ruminococcus/Intestinimonas and Ruminococcus, respectively (Table 7).

Table 7.

Genera of bacteria correlating highly with serum antibody isotypes in E. granulosus infected mice and uninfected mice.

Genus Uninfected (%) Infected (%) Factor Uninfected Infected Spearman Coef p-value
Barnesiella 2.06 2.99 IgG2a 0.2758 0.8682 0.9 0.037386
Ruminococcus 0.13 0.02 IgG1 0.2801 3.4034 –0.9 0.037386
Ruminococcus 0.13 0.02 IgG2b 0.2434 0.8148 –0.9 0.037386
Ruminococcus 0.13 0.02 IgG3 0.2329 1.0469 –1 0
Ruminococcus 0.13 0.02 IgM 0.3879 2.7058 –0.9 0.037386
Clostridium IV 0.04 0.05 IgA 0.1563 0.3758 0.9747 0.004818
Enterorhabdus 0.06 0.08 IgG1 0.2801 3.4034 0.9 0.037386
Intestinimonas 0.15 0.11 IgG2b 0.2434 0.8148 –0.9 0.037386
Escherichia/Shigella 0.39 0.17 IgG 0.7014 3.9271 –1 0
Lachnospiracea Incertaesedis 0.56 0.61 IgA 0.1564 0.3758 0.9747 0.004818
Mucispirillum 1.81 2.72 IgA 0.1564 0.3758 0.9747 0.004818
Clostridium XlVa 2.70 4.19 IgG2b 0.2434 0.8148 0.9 0.037386

Uninfected, uninfected mice; Infected, mice infected with E. granulosus.

FIGURE 4.

FIGURE 4

The correlations of seven physical factors and major genera. The pie charts show relative proportions of major genera in the E. granulosus infected mice and uninfected mice. (Green: Uninfected Group; red: Infection Group), and the circle size represents the reads numbers. Line and arrow type: solid arrow (positive relations), dash “T” (negative relations).

Discussion

The ecological balance of the microbiota in the gut is crucial for maintaining healthy condition (Cani et al., 2008). Disruption of the balance of the gut microbiota is associated with a range of diseases, including colorectal cancer, autoimmune diseases, metabolic diseases, among others (Sokol et al., 2008; Jiang et al., 2015). In this study, we showed that E. granulosus infection increased two genera of gut microbiota: Eisenbergiella and genus Parabacteroides, with most genera remaining unchange. The two genera are in the family Lachnospiraceae. Their increase may impact on human health (Plieskatt et al., 2013), and may be associated with diabetes in mice (Kameyama and Itoh, 2014).

At the OTU level, there were 150 OTUs significantly changed in the infected mice. However, among the OTUs, only 49 OTUs have taxonomic information at genus level with 101 without predicted taxonomic classification information, which limited our further analysis (Table 5). Additionally, the LEfSe analysis also showed genera Eisenbergiella and Parabacteroides increased in the infected mice, suggesting that these two genera of bacteria might be biomarkers for E. granulosus infection. In our study, the genus Eisenbergiella in the family Lachnospiraceae was up-regulated significantly in the infected mice, however, there is very limited biological function information on this genus. Combined with antibody analysis in this study, this genus of bacteria may be associated with a Th2 response.

Another increased genus in Infected Group is Parabacteroides whereas species belonging to the genus Parabacteroides are saccharolytic (Rajilic-Stojanovic and de Vos, 2014), being producers of short chain fatty acids (SCFAs) including acetate, propionate and butyrate as bacterial fermentation products (Cummings et al., 1987; Correa-Oliveira et al., 2016; Lloyd-Price et al., 2016). SCFAs act as links between the microbiota and the host immune system (Correa-Oliveira et al., 2016). The liver is the major systemic organ for SCFA metabolism and consumption (Kim et al., 2014), SCFAs released by the gut and equaled by hepatic uptake (Bloemen et al., 2009). Parabacteroides has evolved to contain a gene encoding a major capsid protein (Rosenwald et al., 2014) one of the phage orthologous groups (Kristensen et al., 2013). One report demonstrated that Parabacteroides was prevalent in diabetic (Wu et al., 2010). The increasing of genus Parabacteroides in hydatid infection may be associated with hepatic alteration.

Functional predictions showed seven pathways of the gut microbiota in the E. granulosus infection group were altered compared with the uninfected group. These pathways included biotin, lipid metabolism, and tryptophan metabolism. The synergistic effect of bacteria leads to the difference of gut flora metabolic pathways due to some or all intestinal bacteria involving in metabolism. Biotin metabolism in the intestine is regulated through transcriptional and post-transcriptional mechanisms. Its balance plays a key role in regulating the absorption and the function of biotin in tissues (Zoetendal et al., 2012). Based on pathway impact analysis, we found that tryptophan metabolism was decreased in the E. granulosus infection group. In mice infected with schistosomes, tryptophan or compounds from tryptophan metabolism were up-regulated and increased in urine which indicate possible problems in tryptophan metabolism in these infected animals (Njagi et al., 1992; Wang et al., 2004).

We showed that the bacterial composition of nine major genera had strong correlations with the levels of IgG, IgG1 and IgG2a antibodies against HCF antigens (Figure 4). The numbers of genera Enterorhabdus, and Clostridium XlVa were positively correlated with IgG1 and IgG2b levels, indicating that these bacteria can be tolerated with those Th2 associated antibodies or Th2 responses may benefit those genera of bacteria. Meanwhile, IgG2a, a Th1 associated antibody, was associated with increased number of genus Barnesiella, indicating Th1 has a role for increasing genus Barnesiella. Our data also showed that Th2 associated antibodies IgG1 and IgG2b and IgG3 decreased numbers of genera Escherichia/Shigella, and Ruminococcus, Ruminococcus/Intestinimonas (Table 7 and Figure 4). Interestingly, Intestinimonas decreased significantly in E. granulosus infection group as a differential genus by LEfSe analysis, perhaps it is associated with some kinds of change, then we concluded that it is highly related to IgG2b by Spearman coefficient correlation analysis and is consistent with the immune background of E. granulosus infection. So IgG2b may play impartment role in inhibition of Intestinimonas. Clostridium has been found to be associated with a number of diseases. It showed that Clostridium may participate in antibiotic-associated diarrhea (Buffie et al., 2015) and damages the human intestine in vitro (Fernandez Miyakawa et al., 2005). Barnesiella is present in the healthy intestinal tract and is influenced by antibiotics, and intestinal colonization with Barnesiella confers resistance to intestinal domination and bloodstream infection with vancomycin-resistant Enterococcus (Ubeda et al., 2013).

In summary, we explored gut microbiota in mice infected with E. granulosus, and found that chronic E. granulosus infection increased 101 OTUs including two genera of gut microbiota in mice. Functional prediction showed seven pathways of gut microbiota were altered, and bacterial composition of major genera had positive correlations with IgG1 and IgG2b in E. granulosus infected mice.

Whereas more than 85% of the genomic sequences between mouse and Homo are conserved, overall gene expression and its regulation are considerably different between the two species (Hugenholtz and de Vos, 2018). Human and mouse seems to be similar at phylum level, Bacteroidetes and Firmicutes are the two major bacterial phyla of the intestinal tract (Rawls et al., 2006). However, we do not know whether E. granulosus infection will affect human intestinal flora in the same way as the mouse and further studies are now required to understand the further possible mechanisms associated with altered colonization resistance after helminth infection and to determine changes in the gut microbiota of patients with CE.

Accession Numbers

The sequence data have been submitted to the GeneBank Sequence Read Archive (Accession Number PRJNA396089).

Author Contributions

WZ, JL, and DM contributed to conception and design of the study. JB organized the database. LH, WQ, and TW finished the animal experiments. HZ, ZZ, and YW performed the statistical analysis. JB and YW wrote the first draft of the manuscript. GG, XZ, and BG wrote sections of the manuscript. All authors contributed to manuscript revision, read and approved the submitted version.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Footnotes

Funding. The study was financially supported by The National Natural Science Foundation of China (NSFC 81460308 and NSFC U1303203).

References

  1. Bloemen J. G., Venema K., Van De Poll M. C., Olde Damink S. W., Buurman W. A., Dejong C. H. (2009). Short chain fatty acids exchange across the gut and liver in humans measured at surgery. Clin. Nutr. 28 657–661. 10.1016/j.clnu.2009.05.011 [DOI] [PubMed] [Google Scholar]
  2. Buffie C. G., Bucci V., Stein R. R., Mckenney P. T., Ling L., Gobourne A., et al. (2015). Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517 205–208. 10.1038/nature13828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cani P. D., Bibiloni R., Knauf C., Waget A., Neyrinck A. M., Delzenne N. M., et al. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes Metab. Res. Rev. 57 1470–1481. 10.2337/db07-1403 [DOI] [PubMed] [Google Scholar]
  4. Casaravilla C., Pittini A., Ruckerl D., Seoane P. I., Jenkins S. J., Macdonald A. S., et al. (2014). Unconventional maturation of dendritic cells induced by particles from the laminated layer of larval Echinococcus granulosus. Infect. Immun. 82 3164–3176. 10.1128/IAI.01959-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen Y. C., Greenbaum J., Shen H., Deng H. W. (2017). Association between gut microbiota and bone health: potential mechanisms and prospective. J. Clin. Endocrinol. Metab. 102 3635–3646. 10.1210/jc.2017-00513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cole J. R., Wang Q., Cardenas E., Fish J., Chai B., Farris R. J., et al. (2009). The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 37 D141–D145. 10.1093/nar/gkn879 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Correa-Oliveira R., Fachi J. L., Vieira A., Sato F. T., Vinolo M. A. (2016). Regulation of immune cell function by short-chain fatty acids. Clin. Transl. Immunol. 5:e73. 10.1038/cti.2016.17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cummings J. H., Pomare E. W., Branch W. J., Naylor C. P., Macfarlane G. T. (1987). Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28 1221–1227. 10.1136/gut.28.10.1221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Elissondo M., Ceballos L., Dopchiz M., Andresiuk V., Alvarez L., Bruni S. S., et al. (2007). In vitro and in vivo effects of flubendazole on Echinococcus granulosus metacestodes. Parasitol. Res. 100 1003–1009. 10.1007/s00436-006-0381-y [DOI] [PubMed] [Google Scholar]
  10. Fernandez Miyakawa M. E., Pistone Creydt V., Uzal F. A., Mcclane B. A., Ibarra C. (2005). Clostridium perfringens enterotoxin damages the human intestine in vitro. Infect. Immun. 73 8407–8410. 10.1128/IAI.73.12.8407-8410.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gavidia C. M., Gonzalez A. E., Zhang W., Mcmanus D. P., Lopera L., Ninaquispe B., et al. (2008). Diagnosis of cystic echinococcosis, central Peruvian Highlands. Emerg. Infect. Dis. 14 260–266. 10.3201/eid1402.061101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gkouskou K. K., Deligianni C., Tsatsanis C., Eliopoulos A. G. (2014). The gut microbiota in mouse models of inflammatory bowel disease. Front. Cell. Infect. Microbiol. 4:28 10.3389/fcimb.2014.00028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gottstein B. (2001). Animal models in parasitology. Contrib. Microbiol. 9 31–44. 10.1159/000060387 [DOI] [PubMed] [Google Scholar]
  14. Guernier V., Brennan B., Yakob L., Milinovich G., Clements A. C., Soares Magalhaes R. J. (2017). Gut microbiota disturbance during helminth infection: can it affect cognition and behaviour of children? BMC Infect. Dis. 17:58. 10.1186/s12879-016-2146-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hugenholtz F., de Vos W. M. (2018). Mouse models for human intestinal microbiota research: a critical evaluation. Cell. Mol. Life Sci. 75 149–160. 10.1007/s00018-017-2693-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jensen A. B., Ajslev T. A., Brunak S., Sorensen T. I. (2015). Long-term risk of cardiovascular and cerebrovascular disease after removal of the colonic microbiota by colectomy: a cohort study based on the Danish National Patient Register from 1996 to 2014. BMJ Open 5:e008702. 10.1136/bmjopen-2015-008702 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jiang H., Ling Z., Zhang Y., Mao H., Ma Z., Yin Y., et al. (2015). Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav. Immun. 48 186–194. 10.1016/j.bbi.2015.03.016 [DOI] [PubMed] [Google Scholar]
  18. Kameyama K., Itoh K. (2014). Intestinal colonization by a Lachnospiraceae bacterium contributes to the development of diabetes in obese mice. Microbes Environ. 29 427–430. 10.1264/jsme2.ME14054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kim C. H., Park J., Kim M. (2014). Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immune Netw. 14 277–288. 10.4110/in.2014.14.6.277 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kittelberger R., Reichel M. P., Jenner J., Heath D. D., Lightowlers M. W., Moro P., et al. (2002). Evaluation of three enzyme-linked immunosorbent assays (ELISAs) for the detection of serum antibodies in sheep infected with Echinococcus granulosus. Vet. Parasitol. 110 57–76. 10.1016/S0304-4017(02)00308-4 [DOI] [PubMed] [Google Scholar]
  21. Kristensen D. M., Waller A. S., Yamada T., Bork P., Mushegian A. R., Koonin E. V. (2013). Orthologous gene clusters and taxon signature genes for viruses of prokaryotes. J. Bacteriol. 195 941–950. 10.1128/JB.01801-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Langille M. G., Zaneveld J., Caporaso J. G., Mcdonald D., Knights D., Reyes J. A., et al. (2013). Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31 814–821. 10.1038/nbt.2676 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lloyd-Price J., Abu-Ali G., Huttenhower C. (2016). The healthy human microbiome. Genome Med. 8:51. 10.1186/s13073-016-0307-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. McManus D. P., Gray D. J., Zhang W., Yang Y. (2012). Diagnosis, treatment, and management of echinococcosis. BMJ 344:e3866. 10.1136/bmj.e3866 [DOI] [PubMed] [Google Scholar]
  25. Mourglia-Ettlin G., Cucher M., Arbildi P., Rosenzvit M., Dematteis S. (2016). Natural and induced antibodies contribute to differential susceptibility to secondary cystic echinococcosis of Balb/c and C57Bl/6 mice. Immunobiology 221 103–115. 10.1016/j.imbio.2015.07.016 [DOI] [PubMed] [Google Scholar]
  26. Nakaya K., Mamuti W., Xiao N., Sato M. O., Wandra T., Nakao M., et al. (2006). Usefulness of severe combined immunodeficiency (scid) and inbred mice for studies of cysticercosis and echinococcosis. Parasitol. Int. 55(Suppl.), S91–S97. 10.1016/j.parint.2005.11.014 [DOI] [PubMed] [Google Scholar]
  27. Njagi E. N., Bender D. A., Okelo G. B. (1992). Tryptophan metabolism and vitamin B6 nutritional status in patients with schistosomiasis mansoni and in infected mice. Parasitology 104(Pt 3), 433–441. 10.1017/S0031182000063691 [DOI] [PubMed] [Google Scholar]
  28. O’Keefe S. J. (2016). Diet, microorganisms and their metabolites, and colon cancer. Nat. Rev. Gastroenterol. Hepatol. 13 691–706. 10.1038/nrgastro.2016.165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Parks D. H., Tyson G. W., Hugenholtz P., Beiko R. G. (2014). STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics 30 3123–3124. 10.1093/bioinformatics/btu494 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Plieskatt J. L., Deenonpoe R., Mulvenna J. P., Krause L., Sripa B., Bethony J. M., et al. (2013). Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. FASEB J. 27 4572–4584. 10.1096/fj.13-232751 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Quast C., Pruesse E., Yilmaz P., Gerken J., Schweer T., Yarza P., et al. (2013). The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41 D590–D596. 10.1093/nar/gks1219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rajilic-Stojanovic M., de Vos W. M. (2014). The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol. Rev. 38 996–1047. 10.1111/1574-6976.12075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ramanan D., Bowcutt R., Lee S. C., Tang M. S., Kurtz Z. D., Ding Y., et al. (2016). Helminth infection promotes colonization resistance via type 2 immunity. Science 352 608–612. 10.1126/science.aaf3229 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rawls J. F., Mahowald M. A., Ley R. E., Gordon J. I. (2006). Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 127 423–433. 10.1016/j.cell.2006.08.043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rigano R., Profumo E., Siracusano A. (1997). New perspectives in the immunology of Echinococcus granulosus infection. Parassitologia 39 275–277. [PubMed] [Google Scholar]
  36. Rosenwald A. G., Murray B., Toth T., Madupu R., Kyrillos A., Arora G. (2014). Evidence for horizontal gene transfer between Chlamydophila pneumoniae and Chlamydia phage. Bacteriophage 4:e965076. 10.4161/21597073.2014.965076 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schloss P. D., Gevers D., Westcott S. L. (2011). Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One 6:e27310. 10.1371/journal.pone.0027310 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Segata N., Izard J., Waldron L., Gevers D., Miropolsky L., Garrett W. S., et al. (2011). Metagenomic biomarker discovery and explanation. Genome Biol. 12:R60. 10.1186/gb-2011-12-6-r60 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermudez-Humaran L. G., Gratadoux J. J., et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 105 16731–16736. 10.1073/pnas.0804812105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sonnenburg J. L., Backhed F. (2016). Diet-microbiota interactions as moderators of human metabolism. Nature 535 56–64. 10.1038/nature18846 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Taylor R. (1990). Interpretation of the correlation coefficient: a basic review. J. Diagn. Med. Sonogr. 6 35–39. 10.1177/875647939000600106 [DOI] [Google Scholar]
  42. Thaiss C. A., Zmora N., Levy M., Elinav E. (2016). The microbiome and innate immunity. Nature 535 65–74. 10.1038/nature18847 [DOI] [PubMed] [Google Scholar]
  43. Ubeda C., Bucci V., Caballero S., Djukovic A., Toussaint N. C., Equinda M., et al. (2013). Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect. Immun. 81 965–973. 10.1128/IAI.01197-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wang H., Li J., Guo B., Zhao L., Zhang Z., Mcmanus D. P., et al. (2016). In vitro culture of Echinococcus multilocularis producing protoscoleces and mouse infection with the cultured vesicles. Parasit. Vectors 9:411. 10.1186/s13071-016-1687-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wang H., Li J., Pu H., Hasan B., Ma J., Jones M. K., et al. (2014). Echinococcus granulosus infection reduces airway inflammation of mice likely through enhancing IL-10 and down-regulation of IL-5 and IL-17A. Parasit. Vectors 7:522. 10.1186/s13071-014-0522-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Wang Q., Garrity G. M., Tiedje J. M., Cole J. R. (2007). Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73 5261–5267. 10.1128/AEM.00062-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wang W., Li J., Yao J., Wang T., Li S., Zheng X., et al. (2017). In vitro and in vivo efficacies of novel carbazole aminoalcohols in the treatment of cystic echinococcosis. J. Antimicrob. Chemother. 72 3122–3130. 10.1093/jac/dkx250 [DOI] [PubMed] [Google Scholar]
  48. Wang Y., Holmes E., Nicholson J. K., Cloarec O., Chollet J., Tanner M., et al. (2004). Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc. Natl. Acad. Sci. U.S.A. 101 12676–12681. 10.1073/pnas.0404878101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Wegener Parfrey L., Jirku M., Sima R., Jalovecka M., Sak B., Grigore K., et al. (2017). A benign helminth alters the host immune system and the gut microbiota in a rat model system. PLoS One 12:e0182205. 10.1371/journal.pone.0182205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Wu X., Ma C., Han L., Nawaz M., Gao F., Zhang X., et al. (2010). Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 61 69–78. 10.1007/s00284-010-9582-9 [DOI] [PubMed] [Google Scholar]
  51. Yu L. C., Wei S. C., Ni Y. H. (2018). Impact of microbiota in colorectal carcinogenesis: lessons from experimental models. Intest. Res. 16 346–357. 10.5217/ir.2018.16.3.346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Zeng M. Y., Inohara N., Nunez G. (2017). Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 10 18–26. 10.1038/mi.2016.75 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Zhang W., Li J., Mcmanus D. P. (2003). Concepts in immunology and diagnosis of hydatid disease. Clin. Microbiol. Rev. 16 18–36. 10.1128/CMR.16.1.18-36.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Zhang W., Wen H., Li J., Lin R., Mcmanus D. P. (2012). Immunology and immunodiagnosis of cystic echinococcosis: an update. Clin. Dev. Immunol. 2012:101895. 10.1155/2012/101895 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Zhang W., You H., Zhang Z., Turson G., Hasyet A., Mcmanus D. P. (2001). Further studies on an intermediate host murine model showing that a primary Echinococcus granulosus infection is protective against subsequent oncospheral challenge. Parasitol. Int. 50 279–283. 10.1016/S1383-5769(01)00086-1 [DOI] [PubMed] [Google Scholar]
  56. Zhang W. B., Jones M. K., Li J., Mcmanus D. P. (2005). Echinococcus granulosus: pre-culture of protoscoleces in vitro significantly increases development and viability of secondary hydatid cysts in mice. Exp. Parasitol. 110 88–90. 10.1016/j.exppara.2005.02.003 [DOI] [PubMed] [Google Scholar]
  57. Zoetendal E. G., Raes J., Van Den Bogert B., Arumugam M., Booijink C. C., Troost F. J., et al. (2012). The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J. 6 1415–1426. 10.1038/ismej.2011.212 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES